|
HS Code |
753097 |
| Chemicalname | Arecoline Hydrobromate |
| Casnumber | 300-08-3 |
| Molecularformula | C8H13NO2·HBr |
| Molecularweight | 252.11 g/mol |
| Appearance | White to off-white crystalline powder |
| Solubility | Soluble in water |
| Meltingpoint | 155-158°C |
| Storageconditions | Store in a cool, dry place, tightly closed |
| Synonyms | Arecoline hydrobromide |
| Purity | Typically ≥98% |
| Odor | Characteristic |
| Usage | Pharmaceutical intermediate and research chemical |
As an accredited Arecoline Hydrobromate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | Arecoline Hydrobromate, 25 grams, sealed in an amber glass bottle with a tamper-evident cap and clear hazard labeling. |
| Shipping | Arecoline Hydrobromate is shipped in tightly sealed containers, protected from light and moisture, and packed according to hazardous chemical regulations. Handling requires appropriate protective gear. The package includes a Material Safety Data Sheet (MSDS). Shipping complies with international and local regulations for chemical transport to ensure safety and integrity during transit. |
| Storage | Arecoline Hydrobromate should be stored in a tightly closed container, away from light, moisture, and incompatible substances. Keep it in a cool, dry, well-ventilated area, ideally at room temperature (15–25°C). Protect it from excessive heat and humidity. Ensure the container is clearly labeled and restrict access to authorized personnel. Follow local safety and chemical storage regulations. |
|
Purity 98%: Arecoline Hydrobromate with 98% purity is used in pharmacological research, where it ensures consistent receptor-binding activity. Melting Point 175°C: Arecoline Hydrobromate with a melting point of 175°C is used in bulk chemical synthesis, where it provides enhanced thermal stability during processing. Molecular Weight 282.18 g/mol: Arecoline Hydrobromate with a molecular weight of 282.18 g/mol is used in standard titration protocols, where it enables accurate dosage calculation. Stability Temperature up to 60°C: Arecoline Hydrobromate stable up to 60°C is used in storage of analytical standards, where it maintains compound integrity over time. Fine Particle Size <50 µm: Arecoline Hydrobromate with a particle size below 50 µm is used in injectable drug formulations, where it allows for improved solubility and uniform suspension. Aqueous Solubility 100 mg/mL: Arecoline Hydrobromate with aqueous solubility of 100 mg/mL is used in laboratory solution preparations, where it facilitates rapid dilution and dispersion. Residual Moisture <0.5%: Arecoline Hydrobromate with residual moisture below 0.5% is used in dry powder blending, where it prevents clumping and ensures homogeneous mixtures. UV Absorbance 260 nm: Arecoline Hydrobromate with UV absorbance at 260 nm is used in spectrometric analysis, where it allows precise quantitative detection. Assay Consistency ±0.2%: Arecoline Hydrobromate with assay variation within ±0.2% is used in clinical reference material production, where it assures batch-to-batch reliability. pH Stability Range 4–8: Arecoline Hydrobromate stable in pH range 4–8 is used in sustained-release drug delivery systems, where it preserves biological activity under physiological conditions. |
Competitive Arecoline Hydrobromate prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please contact us at +8615365186327 or mail to admin@ascent-chem.com.
We will respond to you as soon as possible.
Tel: +8615365186327
Email: admin@ascent-chem.com
Flexible payment, competitive price, premium service - Inquire now!
From our position on the manufacturing floor, handling and producing Arecoline Hydrobromate involves much more than keeping a chemical in stock. The industry often discusses active pharmaceutical ingredients as checkboxes—purity, compliance, source—without digging into the real work behind the compound. The model most in demand here, Arecoline Hydrobromate with a CAS number of 300-08-3, shows up as crystalline, off-white to light yellow, largely due to strictly controlled crystallization and the hydrobromate form.
Chemists and process engineers can appreciate the difference between seeing a product in a brochure and seeing it on a production line. The raw areca nut alkaloid, arecoline, demands careful extraction and conversion. The hydrobromate salt stabilizes the compound and reduces potential volatility during both storage and downstream handling. Experience has convinced us of the compound’s sensitivity to temperature and humidity shifts; even slight deviations interrupt intended crystal formation and purity profiles.
We find that research and pharmaceutical teams often search for product grades without really seeing why the differences matter. Arecoline Hydrobromate that emerges from our process holds to a tight assay specification, often in the neighborhood of 98% minimum, with controlled moisture and closely monitored levels of free hydrobromic acid. Each lot that leaves our warehouse receives inspection down to the last details of melting point and residual solvents. Most customers request documents, but our in-house team tracks batch characteristics daily because the chemical’s consistency has direct impact on downstream syntheses or pharmacological research.
The biggest distinctions between Arecoline Hydrobromate and other related alkaloid salts lie in its chemical activity and its form. Arecoline free base, for example, is harder to store and shows far greater reactivity with atmospheric moisture. The hydrobromate variant holds up much better for laboratory and industrial transport, as we’ve witnessed during stress testing for environmental conditions. Some may claim all versions are more or less interchangeable, but the reality proves otherwise.
Instead of stacking product descriptions, we observe real behavior—how this material dissolves and reacts in aqueous or organic solvents depending on the application, how it integrates in different research workflows, and how it performs under pharmaceutical quality checks. The hydrobromate salt assures greater shelf stability, a cleaner melting point, and easier weighing compared to the free base or the hydrochloride counterpart, which often attracts more moisture and may introduce chloride-based side reactions.
Within our own production spaces, handling this compound pushes us to maintain vigilant hygiene and containment protocols, as arecoline alkaloids possess bioactivity that signals caution. Personnel who operate reactors wear full protection, from gloves to goggles, and we use closed systems for any open transfers or crystallization stages. Dust and airborne trace exposure remain a real concern, so we designed the facility with negative pressure zones, continual HEPA filtration, and routine air monitoring.
Even the chemical’s crystalline habit – typically prismatic or irregular plates – determines the ease of filtration and packaging. Years back, certain lots exhibited finer dust that complicated filtration and encouraged us to fine-tune cooling rates during precipitation. Fine-tuning this step brought greater batch-to-batch repeatability and reduced labor time for subsequent filtration.
Production scale brings its own set of learnings. Small-batch reactions might tolerate some environmental drift, but multi-kilogram crystallizations show any lack of process control through variable yield, altered clarity, or increased impurity profiles. Our investment over the years in better jacketed reactors, precise agitation, and controlled dosing has paid off both in chemical yield and occupational safety. Analytical teams regularly feed back any deviation from the set point ranges to process engineers, closing the loop between synthesis and quality control.
We have also witnessed critical differences in solubility and reactivity depending on the lots’ microstructure. Occasionally, small shifts in solvent ratio or pH during the conversion to the hydrobromate caused differences in filtration times, which in turn affected drying protocols. As we studied archival data and logged small process modifications, patterns became clear about what interventions improved purity without sacrificing yield.
Comparing Arecoline Hydrobromate with other related chemicals highlights why researchers, process chemists, and product formulators gravitate toward it. The free base form of arecoline, while active, brings storage and handling challenges that limit its practicality in most labs. In contrast, hydrochloride salts, commonly reviewed as a substitute, often introduce excess water as part of their crystalline form, sometimes affecting stability or downstream solubility depending on the solvent system in use. Some teams steadfastly request only the hydrobromate form, for both regulatory approval processes and laboratory consistency.
Salts shape the fate of active molecules: the hydrobromide anion reduces hydrolysis rates and tends to keep the molecule closer to its intended purity during storage, even under imperfect temperature control. We’ve examined side-by-side stability trials and found the hydrobromide batches retained color, melting point, and assay for much longer.
Some newer distributors claim universal interchangeability between the various salt forms, but results from actual research and process development show otherwise. We have seen researchers using the hydrochloride form notice logistical problems when they scale beyond lab scale, from shipping issues to stability failures months after purchase. The hydrobromide consistently avoids these pitfalls for organizations focused on repeatable research or process consistency.
Our clients’ most consistent uses of Arecoline Hydrobromate appear in neuropharmacological research, especially when scientists seek a well-studied muscarinic agonist. This compound is fundamental in studying receptor mechanisms and neurotransmitter interactions. Each requirement for documentation is met with data, but researchers turn to our technical support seeking insights on solvent compatibility, shelf life, and compatibility with other excipients, not just purity certificates.
In pharmaceutical R&D pilot lines, the product’s precise melting point and solubility curve often decide the design of process steps for synthesis of other active molecules. Projects involving clinical studies require high reproducibility from lot to lot, underlining the value of our continuous recording and traceability.
Some applications surface in lesser-known research areas—evaluation of plant alkaloid metabolism, preliminary animal testing, and even biochemical pathway mapping. Specialty chemical teams working on structure-activity relationship studies rely on the robust analytical fingerprint, and they often request custom batch sizes or specific moisture content. Over time, we’ve adapted process steps to answer these niche technical requests, so the final crystalline product hits each parameter demanded by the application.
Many teams tell us about the pitfalls of receiving material with questionable origins or inconsistent analysis, especially after ordering through less established supply chains. Impurities or byproducts present serious risks for sensitive pharmacological assays, which depend on known purity profiles and minimal batch-to-batch variation. Intermediate processors on the formulation floor prefer the hydrobromide salt for ease of dissolution and accurate dosing—it lands in the formulation record book with little fuss, compared to salt forms that clump or require additional preparatory steps prior to blending.
Most market players discuss Arecoline Hydrobromate’s technical specifications – purity by HPLC, residual solvents, water content, particle size – as a series of stats. From our perspective, achieving these numbers calls for focus throughout each production step, not just a sign-off on a certificate of analysis. The evidence comes through in the audit trail, quality check points, and, most importantly, in what we have seen in the field.
During routine manufacture, our quality assurance team collects samples from each intermediate stage, not just final product. This strategy solves minor issues before they escalate—a crystal with atypical shape shows up during filtration? We halt the process, adjust cooling or reagent concentration, and verify with analysis before moving to the next stage.
The stability of Arecoline Hydrobromate also ties to the cleanliness of the environment and diligent maintenance of equipment—a less cared-for filtration system, for instance, can seed contamination, which might not appear in mainline testing but emerges in long-term storage. We tackle this by logging every cleaning cycle, rotavap change, and environmental reading. The aim is both consistency and peace of mind for the end user.
Certifications matter mainly in showing that process discipline holds from batch to batch, season to season. During the last decade, increasingly demanding regulatory audits have stressed traceability not just for incoming solvents and areca nut source material, but for every granule of the finished salt. This requirement benefits the research community as well: researchers working with our material can point to a bulletproof history of test results, with full chain-of-custody for every lot shipped.
Upstream factors shape downstream success. Arecoline extraction starts with areca nut sourcing, and variability at the agricultural stage forces manufacturers to pay careful attention to seasonal and regional differences. We buy in regular cycles from vetted suppliers, who understand the need for low pesticide, mold-free nuts, and provide full records. Slight changes in climate or harvest timing alter yield and alkaloid content, and our analysts adjust extraction parameters to maintain consistent output—tweaking solvent ratios, temperature, or pH to match.
We’ve learned that the market occasionally faces disruptions—climatic changes, transportation issues, regulatory slowdowns—and this pushes the price of upstream materials higher, though we still invest in holding sufficient inventory. For pharmaceutical uses, a secure and transparent supply chain offers more confidence than last-minute market purchases. We share sourcing details in confidence with partners when they need verification for certifications or government filings. Daily experience on the procurement side shows that early communication with agricultural partners rewards us with more predictable lots and fewer surprises at the extraction stage.
Many researchers and industrial customers focus tightly on assay numbers but rarely see the effort behind ensuring a stable, contamination-free input stream. Issues like aflatoxin, pesticide residue, or accidental mislabeling rarely appear in glossy product lists but represent serious dangers for any process based on plant-sourced chemicals. We invest in up-front laboratory screening and reject any suspect consignments; a missed contaminant at this stage can multiply headaches down the line, from synthesis degradation to failed batch clearance.
Process audit visits from external specialists always reveal what paper records cannot: the real-world discipline of a chemical plant and the experience of the operators. These professionals follow the production from tank to tank, questioning every record, probing at any weak link. We treat audits as shared learning exercises, and we’ve grown by adopting best practices from international standards, from documentation style to in-process test procedures.
Over time, we invested in a process control software suite to log every input, adjustment, and batch number. It provides traceability and offers transparency for any customer or regulator needing integrated reports. But the value comes less from the software and more from our team’s practice of analyzing out-of-spec events and applying lessons learned to both equipment and personnel training. We do not settle for ‘close enough’ and teach this attention to detail through continual refresher programs and transparent review of both successes and failures.
Customers who audit our facility, and who understand the difference between paperwork and practice, return for repeat business. They have told us horror stories about chemical orders gone wrong—incorrect particle sizing, off-color product, failed solubility tests on arrival. These incidents highlight the gap between resellers and genuine manufacturers who monitor lot numbers, environmental readings, and operator procedures through every shift.
The industry’s expectations for Arecoline Hydrobromate continue to rise, driven by both regulatory scrutiny and the push for more transparent supply chains. Information requests from clients have shifted from simple data sheets to deep-dive safety documentation, route-of-synthesis breakdowns, and nuanced batch history. We welcome this trend. It aligns with our internal culture of recordkeeping, traceability, and open communication.
Pharmaceutical and research regulations now demand detailed alignment with Good Manufacturing Practice, and we meet this with investment in both equipment and staff training. We have seen significant value in retaining long-term personnel for laboratory, quality, and production posts. Their skill and judgment prevent both overt and subtle quality lapses, saving costly downtime or batch rejection.
Emerging sustainability and safety expectations put further pressure on manufacturers. Our team continually evaluates waste reduction, solvent recovery, and energy conservation options. Reducing waste load and improving solvent recycling directly affects both cost and environmental impact. We have shifted several steps toward greener, closed-loop practices that generate less environmental byproduct, a commitment most evident not in paperwork but in reduced waste output measured by third party audits.
Knowledge sharing within the community strengthens the supply chain. We attend technical forums and share findings from process optimization, impurity tracking, and quality audit performance. Customers benefit, whether they are working in a research institute or scaling up to pharmaceutical production. We have contributed both anonymous process data and operational insights to industry knowledge bases, ensuring Arecoline Hydrobromate quality benchmarks continually rise across the sector.
Offering Arecoline Hydrobromate that stands up to real-world use means remaining active at every stage of its lifecycle, from raw material selection through process optimization, environmental control, and final delivery. The chemical’s value rests in transparent manufacturing and an ongoing drive to refine process, documentation, and customer support. We draw from every audit, result, and customer comment to adjust protocols and improve the finished product.
We know from long experience with both bulk and specialty clients that each batch serves as both a deliverable and a test of the manufacturer’s discipline. Quality, purity, and consistency result from deliberate choices at every step—not only to satisfy auditors and regulators but to foster safer research, more reliable pharmaceutical development, and greater trust between supplier and end user.
Above all, the ongoing effort to deliver Arecoline Hydrobromate with these high standards underscores the difference between seeing chemistry as commodity and seeing it as craft and responsibility. Our story continues, informed both by data and the hands-on lessons only gained through years of attention to detail and open dialogue with those who use our product most.